Gary W. Pace Acquires 30,000 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) Stock

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) Director Gary W. Pace acquired 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The shares were bought at an average cost of $1.37 per share, for a total transaction of $41,100.00. Following the transaction, the director now owns 697,761 shares […]

Related Keywords

California ,United States ,America , ,Nasdaq ,America Corp ,Pricet Rowe Associates Inc ,Walleye Capital ,Cardiff Oncology Inc ,Dimensional Fund Advisors ,Securities Exchange Commission ,Topco Ltd ,Cardiff Oncology ,Get Free Report ,Director Gary ,Exchange Commission ,Fund Advisors ,Polo Like Kinase ,Cardiff Oncology Daily ,Nasdaq Crdf ,Acrdf ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,